{"protocolSection": {"identificationModule": {"nctId": "NCT03528577", "orgStudyIdInfo": {"id": "CLR_17_08"}, "organization": {"fullName": "Sun Pharmaceutical Industries Limited", "class": "INDUSTRY"}, "briefTitle": "A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)", "officialTitle": "A Randomized, Single-Dose, Double-Blind, Double-Dummy, Four-Period, Four-Sequence, Four-Treatment, Placebo and Active Controlled, Comparative, Multiple-Center, Crossover-Design, Bronchoprovocation Study to Evaluate the Pharmacodynamic Equivalence of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited) to PROAIR\u00ae HFA (Albuterol Sulfate) Inhalation Aerosol, eq 90 mcg Base (Teva Respiratory, LLC) in Subjects With Stable, Mild Asthma"}, "statusModule": {"statusVerifiedDate": "2021-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2018-09-22", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-03-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-08-03", "type": "ACTUAL"}, "studyFirstSubmitDate": "2018-04-21", "studyFirstSubmitQcDate": "2018-05-04", "studyFirstPostDateStruct": {"date": "2018-05-18", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2020-07-18", "resultsFirstSubmitQcDate": "2021-01-02", "resultsFirstPostDateStruct": {"date": "2021-01-22", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-01-02", "lastUpdatePostDateStruct": {"date": "2021-01-22", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Sun Pharmaceutical Industries Limited", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "To Evaluate the Pharmacodynamic Equivalence of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg base (Sun Pharmaceuticals Industries Limited) to PROAIR\u00ae HFA (albuterol sulfate) Inhalation Aerosol, eq 90 mcg base (Teva Respiratory, LLC) in Subjects With Stable, Mild Asthma"}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 128, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Test", "type": "EXPERIMENTAL", "description": "Albuterol Sulfate Inhalation Aerosol, eq 90 mcg", "interventionNames": ["Drug: Zero-dose", "Drug: 90 mcg of PROAIR\u00ae HFA", "Drug: 180 mcg of 90 mcg of PROAIR\u00ae HFA", "Drug: 90 mcg of albuterol sulfate inhalation aerosol"]}, {"label": "Reference", "type": "ACTIVE_COMPARATOR", "description": "PROAIR\u00ae HFA (albuterol sulfate) Inhalation Aerosol, eq 90 mcg", "interventionNames": ["Drug: Zero-dose", "Drug: 90 mcg of PROAIR\u00ae HFA", "Drug: 180 mcg of 90 mcg of PROAIR\u00ae HFA", "Drug: 90 mcg of albuterol sulfate inhalation aerosol"]}, {"label": "Test Placebo", "type": "PLACEBO_COMPARATOR", "description": "Placebo for Albuterol Sulfate Inhalation Aerosol", "interventionNames": ["Drug: Zero-dose", "Drug: 90 mcg of PROAIR\u00ae HFA", "Drug: 180 mcg of 90 mcg of PROAIR\u00ae HFA", "Drug: 90 mcg of albuterol sulfate inhalation aerosol"]}, {"label": "Reference Placebo", "type": "PLACEBO_COMPARATOR", "description": "Placebo for Albuterol Sulfate Inhalation Aerosol", "interventionNames": ["Drug: Zero-dose", "Drug: 90 mcg of PROAIR\u00ae HFA", "Drug: 180 mcg of 90 mcg of PROAIR\u00ae HFA", "Drug: 90 mcg of albuterol sulfate inhalation aerosol"]}], "interventions": [{"type": "DRUG", "name": "Zero-dose", "description": "Treatment A", "armGroupLabels": ["Reference", "Reference Placebo", "Test", "Test Placebo"]}, {"type": "DRUG", "name": "90 mcg of PROAIR\u00ae HFA", "description": "Treatment B", "armGroupLabels": ["Reference", "Reference Placebo", "Test", "Test Placebo"]}, {"type": "DRUG", "name": "180 mcg of 90 mcg of PROAIR\u00ae HFA", "description": "Treatment C", "armGroupLabels": ["Reference", "Reference Placebo", "Test", "Test Placebo"]}, {"type": "DRUG", "name": "90 mcg of albuterol sulfate inhalation aerosol", "description": "Treatment D", "armGroupLabels": ["Reference", "Reference Placebo", "Test", "Test Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Pharmacodynamic Endpoint Post-dose PC20", "description": "The primary pharmacodynamic endpoint is the post-dose PC20, which is the provocative concentration of methacholine challenge agent required to reduce the forced expiry volume in one second (FEV1) by 20%, following the administration of different doses of albuterol (or placebo) by inhalation.\n\nPrimary analysis group -pharmacodynamic population.", "timeFrame": "Approximately 15 minutes after last inhalation of study product"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Men or non-pregnant women 18 to 65 years of age.\n2. Signed informed consent form that meets all criteria of current Food and Drug Administration (FDA) regulations.\n3. Females of childbearing potential must not be pregnant or lactating (as confirmed by a negative urine pregnancy test\n4. Ability to use inhalation aerosol correctly.\n\nExclusion Criteria:\n\n1. Any clinically significant finding on physical exam in the opinion of the Investigator, would compromise subject's safety or data integrity.\n2. Employees of the Investigator or research center or their immediate family members.\n3. Previous participation in this study.\n4. Inability to understand the requirements of the study and the relative information and are unable or not willing to comply with the study protocol.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "SPARC Site 02", "city": "Miami Lakes", "state": "Florida", "zip": "33014", "country": "United States", "geoPoint": {"lat": 25.90871, "lon": -80.30866}}, {"facility": "SPARC site 01", "city": "Bethesda", "state": "Maryland", "zip": "20814", "country": "United States", "geoPoint": {"lat": 38.98067, "lon": -77.10026}}, {"facility": "SPARC Site 04", "city": "Saint Louis", "state": "Missouri", "zip": "63141", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "SPARC Site 06", "city": "Gastonia", "state": "North Carolina", "zip": "28054", "country": "United States", "geoPoint": {"lat": 35.26208, "lon": -81.1873}}, {"facility": "SPARC Site 05", "city": "Edmond", "state": "Oklahoma", "zip": "73034", "country": "United States", "geoPoint": {"lat": 35.65283, "lon": -97.4781}}, {"facility": "SPARC Site 07", "city": "Warwick", "state": "Rhode Island", "zip": "02886", "country": "United States", "geoPoint": {"lat": 41.7001, "lon": -71.41617}}, {"facility": "SPARC Site 08", "city": "Boerne", "state": "Texas", "zip": "78006", "country": "United States", "geoPoint": {"lat": 29.79466, "lon": -98.73197}}, {"facility": "SPARC Site 03", "city": "Waco", "state": "Texas", "zip": "76712", "country": "United States", "geoPoint": {"lat": 31.54933, "lon": -97.14667}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "Treatments were administered according to a four-treatment, four-period, four-sequence design.\n\n124 eligible subjects were randomized to each one of the four sequences: ABCD\n\nSequence\n\nSequence 1 : A B C D Sequence 2: D C B A Sequence 3: C A D B Sequence 4: B D A C", "groups": [{"id": "FG000", "title": "Total", "description": "Treatment A: Zero-dose : Two different Reference Placebo inhalers and two different Test Placebo inhalers\n\nTreatment B: 90 mcg of Reference : One Reference inhaler, one Reference Placebo inhaler, and two different Test Placebo inhalers\n\nTreatment C: 180 mcg of Reference Two different Reference inhalers and two different Test Placebo inhalers\n\nTreatment D: 90 mcg of Test One Test inhaler, one Test Placebo inhaler, and two different Reference Placebo inhalers"}], "periods": [{"title": "Sequence 1", "milestones": [{"type": "STARTED", "comment": "128 subjects with persistent bronchial asthma were randomized during the study.", "achievements": [{"groupId": "FG000", "numSubjects": "128"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.", "numSubjects": "126"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}]}], "dropWithdraws": [{"type": "Failed Spirometry", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "Restricted medication", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}]}, {"title": "Sequence 2", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "128"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "125"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "Failed Spirometry", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}]}, {"title": "Sequence 3", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "128"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "127"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "1"}]}], "dropWithdraws": [{"type": "Failed Spirometry", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}]}, {"title": "Sequence 4", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "128"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "125"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}]}], "dropWithdraws": [{"type": "Failed Spirometry", "reasons": [{"groupId": "FG000", "numSubjects": "2"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Overall Baseline", "description": "Summary of Demographic Data and Baseline Characteristics (Safety Population)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "128"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "34.7", "spread": "12.2"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "71"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "57"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "32"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "96"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Tobacco Use", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Number of years patient has suffered from symptoms caused by asthma", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "23.62", "spread": "13.17"}]}]}]}, {"title": "FEV1 (Pre-saline)", "description": "FEV1 is Forced Expiratory Volume (flow rate) in 1 second", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Litre", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "3.20", "spread": "0.72"}]}]}]}, {"title": "FEV1 (Post-saline)", "description": "FEV1 is Forced Expiratory Volume (flow rate) in 1 second", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Litre", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "3.23", "spread": "0.74"}]}]}]}, {"title": "PC20 FEV1", "description": "PC20 is Provocative concentration (mg/mL) of methacholine required to reduce FEV1 by 20%\n\nFEV1 is Forced Expiratory Volume (flow rate) in 1 second", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mg/mL", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "0.95", "spread": "1.36"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Pharmacodynamic Endpoint Post-dose PC20", "description": "The primary pharmacodynamic endpoint is the post-dose PC20, which is the provocative concentration of methacholine challenge agent required to reduce the forced expiry volume in one second (FEV1) by 20%, following the administration of different doses of albuterol (or placebo) by inhalation.\n\nPrimary analysis group -pharmacodynamic population.", "populationDescription": "The statistical analysis was performed based on the Dose-Scale approach. This approach was referenced in FDA's draft Guidance on albuterol sulfate metered/inhalation and described in FDA's draft Guidance on Orlistat capsule. The PC20 data from various treatments (such as placebo, 90 mcg Test, 90 mcg Reference and 180 mcg Reference) from different study period was pooled to perform the Dose-Scale model using NONMEM. Therefore, per test arm values were not reported.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "90% Confidence Interval", "unitOfMeasure": "mg/mL", "timeFrame": "Approximately 15 minutes after last inhalation of study product", "groups": [{"id": "OG000", "title": "Primary Analysis Group", "description": "This group included all randomized subjects who:\n\n1. completed at least 1 of the 4 randomized treatment periods with an evaluable PC20FEV1.\n2. were compliant with study treatment dosing procedures.\n3. did not use any restricted concomitant medications.\n4. did not have any other significant protocol deviations."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "126"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "114", "lowerLimit": "52.8", "upperLimit": "162.0"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0.5", "timeFrame": "6 weeks", "description": "It is the approximate duration over which adverse event data were collected", "eventGroups": [{"id": "EG000", "title": "Treatment A", "description": "Zero-dose", "deathsNumAffected": 0, "deathsNumAtRisk": 125, "seriousNumAffected": 0, "seriousNumAtRisk": 125, "otherNumAffected": 7, "otherNumAtRisk": 125}, {"id": "EG001", "title": "Treatment B", "description": "90 mcg of Reference (PROAIR\u00ae HFA)", "deathsNumAffected": 0, "deathsNumAtRisk": 125, "seriousNumAffected": 0, "seriousNumAtRisk": 125, "otherNumAffected": 3, "otherNumAtRisk": 125}, {"id": "EG002", "title": "Treatment C", "description": "180 mcg of Reference (PROAIR\u00ae HFA)", "deathsNumAffected": 0, "deathsNumAtRisk": 123, "seriousNumAffected": 0, "seriousNumAtRisk": 123, "otherNumAffected": 9, "otherNumAtRisk": 123}, {"id": "EG003", "title": "Treatment D", "description": "90 mcg of Test (Albuterol Sulfate HFA Inhalation Aerosol)", "deathsNumAffected": 0, "deathsNumAtRisk": 126, "seriousNumAffected": 0, "seriousNumAtRisk": 126, "otherNumAffected": 5, "otherNumAtRisk": 126}], "otherEvents": [{"term": "influenza", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 126}]}, {"term": "Hypothyroidism", "organSystem": "Endocrine disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "nausea", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "chest discomfort", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "gastroenteritis", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 126}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "FEV1/FVC ratio", "organSystem": "Investigations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "Hypoglycaemia", "organSystem": "Metabolism and nutrition disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 126}]}, {"term": "arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "Myalgia", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 126}]}, {"term": "dizziness", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "headache", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "tension headache", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "anxiety", "organSystem": "Psychiatric disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "hypoxia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 126}]}, {"term": "accelerated hypertension", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}, {"term": "flushing", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 125}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 123}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 126}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true}, "pointOfContact": {"title": "Clinical Trials", "organization": "SPIL", "email": "clinical.trials@sparcmail.com", "phone": "912266455645"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2018-12-21", "uploadDate": "2020-07-18T06:34", "filename": "SAP_001.pdf", "size": 1211939}, {"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2018-04-17", "uploadDate": "2020-08-14T02:55", "filename": "Prot_002.pdf", "size": 732016}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2020-07-31", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000000420", "term": "Albuterol"}, {"id": "D000017265", "term": "Procaterol"}], "ancestors": [{"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000015149", "term": "Tocolytic Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000013566", "term": "Sympathomimetics"}], "browseLeaves": [{"id": "M3767", "name": "Albuterol", "asFound": "Mental State Examination", "relevance": "HIGH"}, {"id": "M19560", "name": "Procaterol", "asFound": "IFN-alfa-2", "relevance": "HIGH"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M17869", "name": "Tocolytic Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M16345", "name": "Sympathomimetics", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}